BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12357359)

  • 21. Translocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia.
    Sandoval C; Head DR; Mirro J; Behm FG; Ayers GD; Raimondi SC
    Leukemia; 1992 Jun; 6(6):513-9. PubMed ID: 1602790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO.
    Kuchenbauer F; Schnittger S; Look T; Gilliland G; Tenen D; Haferlach T; Hiddemann W; Buske C; Schoch C
    Br J Haematol; 2006 Sep; 134(6):616-9. PubMed ID: 16938118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
    Perea G; Lasa A; Aventín A; Domingo A; Villamor N; Queipo de Llano MP; Llorente A; Juncà J; Palacios C; Fernández C; Gallart M; Font L; Tormo M; Florensa L; Bargay J; Martí JM; Vivancos P; Torres P; Berlanga JJ; Badell I; Brunet S; Sierra J; Nomdedéu JF;
    Leukemia; 2006 Jan; 20(1):87-94. PubMed ID: 16281071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity.
    Ferrara F; Del Vecchio L
    Haematologica; 2002 Mar; 87(3):306-19. PubMed ID: 11869944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
    Huang L; Abruzzo LV; Valbuena JR; Medeiros LJ; Lin P
    Am J Clin Pathol; 2006 Feb; 125(2):267-72. PubMed ID: 16393685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of dual-color fluorescence in situ hybridization in acute myeloid leukemia with t (8; 21)].
    Li CW; Bo LJ; Dai Y; Liu XP; Qin S; Liu SH; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):32-5. PubMed ID: 16732938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocation (10;11)(p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism.
    Stasevich I; Utskevich R; Kustanovich A; Litvinko N; Savitskaya T; Chernyavskaya S; Saharova O; Aleinikova O
    Cancer Genet Cytogenet; 2006 Sep; 169(2):114-20. PubMed ID: 16938568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
    Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.
    Chillón MC; Fernández C; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; González M; Miguel JF
    Hematol J; 2004; 5(3):239-46. PubMed ID: 15167911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia.
    Maruyama F; Yang P; Stass SA; Cork A; Freireich EJ; Lee MS; Chang KS
    Cancer Res; 1993 Oct; 53(19):4449-51. PubMed ID: 8402610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
    Nguyen S; Leblanc T; Fenaux P; Witz F; Blaise D; Pigneux A; Thomas X; Rigal-Huguet F; Lioure B; Auvrignon A; Fière D; Reiffers J; Castaigne S; Leverger G; Harousseau JL; Socié G; Dombret H
    Blood; 2002 May; 99(10):3517-23. PubMed ID: 11986202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematological features and treatment outcome in acute myeloid leukemia with t(8;21).
    Ma SK; Au WY; Kwong YL; Lam CK; Liang RH; Chan LC
    Hematol Oncol; 1997 May; 15(2):93-103. PubMed ID: 9375034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AML1-ETO positive AML: first report from India.
    Dutta P; Hasan SK; Sazawal S; Kumar B; Bhattacharyya J; Jain M; Tyagi S; Kumar R; Pati HP; Saxena R
    Indian J Pathol Microbiol; 2007 Jul; 50(3):652-4. PubMed ID: 17883173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21).
    Schwyzer R; Sherman GG; Cohn RJ; Poole JE; Willem P
    Med Pediatr Oncol; 1998 Sep; 31(3):144-9. PubMed ID: 9722895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.